Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Quan

Showing results (641-650 of 691) with videos related to

Pageof 70
Sort By:
Human Gene Therapy|September 10, 2005
Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine modelsBin Yao, Qiu-Ming He, Ling Tian, et al.
Molecular Biology Reports|August 19, 2009
Down-regulation of Pkd2 by siRNAs suppresses cell-cell adhesion in the mouse melanoma cellsGuo-Hui Bian, Ge Cao, Xiao-Yan Lv, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 22, 2011
SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivoZhi-Xing Cao, Ren-Lin Zheng, Hong-Jun Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2024
Differential modulation of pain and associated anxiety by GABAergic neuronal circuits in the lateral habenulaTeng Chen, Wen-Bo Liu, Sheng-Jie Zhu, et al.
Molecular Cancer Therapeutics|February 10, 2012
SKLB1206, a novel orally available multikinase inhibitor targeting EGFR activating and T790M mutants, ErbB2, ErbB4, and VEGFR2, displays potent antitumor activity both in vitro and in vivoYouli Pan, Yong Xu, Shan Feng, et al.
Journal of Cancer Research and Clinical Oncology|April 6, 2020
Prognostic significance of tumor poliovirus receptor and CTLA4 expression in patients with surgically resected non-small-cell lung cancerHui You, Yi-Zhong Zhang, Huan-Ling Lai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptorYou Lu, Yu-quan Wei, Ling Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Intratumoral expression of mature human neutrophil peptide-1 mediates antitumor immunity in miceYong-Sheng Wang, Dan Li, Hua-Shan Shi, et al.
Scientific Reports|November 14, 2015
Treatment of dextran sodium sulfate-induced experimental colitis by adoptive transfer of peritoneal cellsTing Liu, Jun Ren, Wei Wang, et al.
Nature Microbiology|January 9, 2019
TesG is a type I secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infectionKelei Zhao, Wujiao Li, Jing Li, et al.
Pageof 70

Showing results (641-650 of 691) with videos related to

Sort By:
Pageof 70
Human Gene Therapy|September 10, 2005
Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine modelsBin Yao, Qiu-Ming He, Ling Tian, et al.
Molecular Biology Reports|August 19, 2009
Down-regulation of Pkd2 by siRNAs suppresses cell-cell adhesion in the mouse melanoma cellsGuo-Hui Bian, Ge Cao, Xiao-Yan Lv, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 22, 2011
SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivoZhi-Xing Cao, Ren-Lin Zheng, Hong-Jun Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2024
Differential modulation of pain and associated anxiety by GABAergic neuronal circuits in the lateral habenulaTeng Chen, Wen-Bo Liu, Sheng-Jie Zhu, et al.
Molecular Cancer Therapeutics|February 10, 2012
SKLB1206, a novel orally available multikinase inhibitor targeting EGFR activating and T790M mutants, ErbB2, ErbB4, and VEGFR2, displays potent antitumor activity both in vitro and in vivoYouli Pan, Yong Xu, Shan Feng, et al.
Journal of Cancer Research and Clinical Oncology|April 6, 2020
Prognostic significance of tumor poliovirus receptor and CTLA4 expression in patients with surgically resected non-small-cell lung cancerHui You, Yi-Zhong Zhang, Huan-Ling Lai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptorYou Lu, Yu-quan Wei, Ling Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Intratumoral expression of mature human neutrophil peptide-1 mediates antitumor immunity in miceYong-Sheng Wang, Dan Li, Hua-Shan Shi, et al.
Scientific Reports|November 14, 2015
Treatment of dextran sodium sulfate-induced experimental colitis by adoptive transfer of peritoneal cellsTing Liu, Jun Ren, Wei Wang, et al.
Nature Microbiology|January 9, 2019
TesG is a type I secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infectionKelei Zhao, Wujiao Li, Jing Li, et al.
Pageof 70